Please join us for ToxTime with Joseph Jones, Ph.D., NRCC-TC, Chief Operating Officer at USDTL.
We will be discussing the evolution of drug testing in various newborn specimen types followed by a brief Q&A.
The pros and cons of newborn specimen types
The evolution of newborn testing from urine to meconium to umbilical cord tissue
A brief overview of previous studies